Assessment of erythropoietin levels and some iron indices in chronic renal failure and liver cirrhosis patients

Disease Markers

Volumn 15, Issue 4, 1999, Pages 229-236

  Mady, Essam ^a,b,c   Wissa, Gehane ^a   Khalifa, Ali ^b   El Sabbagh, Mahmoud ^a  

^a Ain Shams University   (Egypt)

^b Faculty of Veterinary Medicine   (Egypt)

^c KING FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Chronic renal failure; Erythropoietin; Iron indices; Liver cirrhosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; ERYTHROPOIETIN; FERRITIN; IRON; NITROGEN; UREA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD CELL COUNT; BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FERRITIN BLOOD LEVEL; HEMODIALYSIS; HUMAN; IRON BINDING CAPACITY; KIDNEY FUNCTION; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL;

EID: 0033381208     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/947857     Document Type: Article

References (39)

1. th ed. (1994) 1-24.
2. rd ed., (1997) 279-321.
3. [3] Fisher, J.W. Mechanism of the anemia of chronic renal failure. Nephron 25, (1980) 106-111.
4. [4] Eschbach, J.W. Nephrology forum: The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin. Kidney Int. 35, (1989) 134-148.
5. [5] McGonigle, R.J.S., Husserl, F., Wallin, J.D. and Fisher, J.W. Hemodialysis and continuous peritoneal dialysis effects on erythropoiesis in renal failure. Kidney Int. 25, (1984) 430-436.
6. [6] Eschbach, J.W., Egrie, J.C., Downing, M.R., Browne, J.K. and Adamson, J.W. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N. Engl. J. Med. 316, (1987) 73-78
7. [7] Sikole, A., Stojanovic, A., Polenakovic, M., Petrusevska, G., Sadikario, S., Saso, R. and Jovanovski, M. How erythropoietin affects bone marrow of uremic patients. Am. J. Nephrol. 17, (1997) 128-136.
8. [8] Schwartz, K.A., Dombrouski, J., Burnatowska-Heldin, M. and Mayor, G. Microcytic anemia in dialysis patients: Reversible marker of aluminium toxicity. Am. J. Kidney Dis. 9, (1987) 217-223.
9. [9] Cunningham, J., Sharman, V.L., Goodwin, F.J. and Marsh, F.P. Do patients receiving hemodialysis need folic acid supplements? Br. Med. J. 282, (1981) 1582.
10. nd ed., (1981) 1-34.
11. [11] Seguchi, C., Shima, T., Misaki, M., Takarada, Y. and Okazaki, T. Serum erythropoietin concentrations and iron status in patients on chronic hemodialysis. Clin. Chem. 38, (1992) 199-203.
12. [12] Graber, S.F. and Krantz, S.B. Hematopoietic growth factors. Erythropoietin: Biology and clinical use. Hematol. Oncol. Clin. N. Am. 3(3), (1989) 369-400.
13. [13] Koury, M.J., Bondurant, M.C., Graber, S.E. and Sawver, S.T. Erythropoietin messenger RNA levels in developing mice and transfer of 1125-erythropoietin by the placenta. J. Clin. Invest. 82, (1988) 154.
14. [14] Maxwell, P.H., Ferguson, D.J.B., Osmond, M.K., Pugh, C.W., Heryet, A., Doe, B.G., Johnson, M.H. and Ratcliffe, P.J. Expression of a homologously recombined erythropoietin-SV40T antigen fusion gene in mouse liver: Evidence for erythropoietin production by its cells. Blood 84, (1994) 1823-1830.
15. [15] Nissenson, A.R. Erythropoietin overview. Blood Purif. 12(1), (1994) 6-13.
16. [16] Erslev, A.J. and Besarab, A. Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure. Kidney Int. 51, (1997) 622-630.
17. [17] Teruel, J.L., Marcen, R., Navarro, J.F., Villafruela, J.J., Lucas, M.F., Rivera, M. and Oruno, J. Influence of body iron stores on the serum erythropoietin concentration in hemodialyzed patients. Am. J. Nephrol. 14(2), (1994) 95-98.
18. [18] Caro, J., Zon, L., Silver, R., Miller, O. and Erslev, A.J. Erythropoietin in liver tissue extracts and in liver perfusates from hypoxic rats. Am. J. Physiol 244, (1983) E431-E34.
19. [19] Cassidy, M.J., De Jager, C., Ibrahim, O., Camachio, P. and Robson, S. Peripheral blood mononuclear cells from patients with chronic renal failure release factors which suppress erythropoietin secretion in vitro. Nephrol. Dial. Transplant. 9(7), (1994) 775-779.
20. th ed., (1991) 37-65.
21. [21] Ceriotti, F. and Ceriotti, G. Improved direct specific determination of serum iron and total iron-binding capacity. Clin. Chem. 26, (1980) 327-331.
22. [22] Forman, D.T. and Parker, S.L. The measurement and interpretation of serum ferritin. Ann. Clin. Lab. Sci. 10, (1980) 345-350.
23. [23] Garcia, J.F., Sherwood, J. and Goldwasser, E. Radioimmunoassay of erythropoietin. Blood Cells 5, (1979) 405-419.
24. [24] Woitge, H.W., Seibel, M.J. and Ziegler, R. Comparison of total and bone-specific alkaline phosphatase in patients with non-skeletal disorders of metabolic bone diseases. Clin. Chem. 42, (1996) 1796-1804.
25. [25] Schlageter, M.H., Toubert, M.E., Padgomiak, M.P. and Najean, Y. Radioimmunoassay of erythropoietin: Analytical performance and clinical use in hematology. Clin. Chem. 36, (1990) 1731-1735.
26. [26] Pollock, C.A., Wyndham, R., Collett, P.V., Elder, G., Field, M.G., Kalowski, S., Lawrence, J.R., Waugh, D.A. and George, C.R.P. Effects of erythropoietin therapy on the lipid profile in end-stage renal failure. Kidney Int. 45, (1994) 897-902.
27. [27] Jensen, J.D., Jensen, L.W., Madsen, J.K. and Poulsen, L. The metabolism of erythropoietin in liver cirrhosis patients compared with healthy volunteers. Eur. J. Hematol. 54(2), (1995) 111-116.
28. [28] Macdougal, I.C., Tucker, B., Thompson, J., Tomson, C.R.V., Baker, L.R.I. and Raine, A.E.G. A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney Int. 50, (1996) 1694-1699.
29. [29] Meierhenrich, R., Jedicke, H., Voigt, A. and Lange, H. The effect of erythropoietin on lactate, pyruvate and excess lactate, under physical exercise in dialysis patients. Clin. Nephrol. 45(2), (1996) 90-96.
30. [30] Steffensen, G., Aunsholt, N.A. and Povlsen, J.V. Evidence that treatment of ESRD patients with recombinant human erythropoietin induces immunosuppression without affecting the distribution of peripheral blood mononuclear cell subpopulations. Clin. Nephrol. 45(2), (1996) 98-103.
31. [31] Karivone, S. and Izuya S. Relationship between erythropoietin and chronic renal failure. Kidney Dialysis (suppl 1), (1988) 144-148.
32. [32] Tanebe, M., Teshima, S., Hanyu, T. and Hayashi, Y. Rapid and sensitive method for erythropoietin determination in serum. Clin. Chem. 38, (1992) 1752-1755.
33. [33] Morris, K. and Coulthard, M. End-stage kidneys are capable of increased erythropoietin production. Pediatr. Nephrol. 7(3), (1993) 273-275.
34. [34] Cotes, P.M., Pippard, M.J., Reid, C.D.L., Winearls, C.G., Oliver, D.O. and Royston, J.P. Characterization of the anemia of chronic renal failure and the method of its correction by a preparation of human erythropoietin(r-HuEPO). An investigation of the pharmaco-kinetics of intravenous erythropoietin and its effects on erythrokinetics. Q. J. Med. 70, (1989) 113-117.
35. [35] Pirisi, M., Fabris, C., Falleti, E., Soardo, G., Toniutto, P., Gonano, F. and Bartolli, E. Evidence for a multifactorial control of serum erythropoietin concentration in liver disease. Clin. Chim. Acta 19, 219(1-2), (1993) 47-55.
36. [36] Ohigashi, T., Tachibana, M., Deguchi, N. and Tazaki, H. Plasma erythropoietin concentration in chronic renal failure measured by radioimmunoassay. J. Jpn. Soc. Dialysis Ther. 21, (1988) 855-860.
37. [37] Rhyner, K., Eglie, F., Niemoller, M., Wieczorek, A., Germinger, P. and Vetter, W. Serum erythropoietin werte bei vershiedenen krankheitszustanden. Nephron 51(suppl 1), (1989) 39-46.
38. [38] Andre, M., Ferster, A., Toppet, M., Fondo, P., Dratwa, M. and Bergmann, P. Performance of an immunoradiometric assay of erythropoietin and results of specimens from anemic and polycythemic patients. Clin. Chem. 38, (1992) 758-763.
39. [39] Zhang, F., Ganong, R.F., Richards, G.K. and Brox, A.G. Anemia of chronic renal failure: characterization in the mouse and correction with human recombinant erythropoietin. Nephron 72(4), (1996) 651-654.